Dr. Zhongxing Liao
Claim this profileM D Anderson Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
3 reported clinical trials
12 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
2Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
M D Anderson Cancer Center
MD Anderson In The Woodlands
Clinical Trials Zhongxing Liao is currently running
Image-Guided Radiation Therapy
for Lung Cancer
This partially randomized phase I/II trial studies the side effects and best dose of image-guided, intensity-modulated photon or proton beam radiation therapy and to see how well they work in treating patients with stage II-IIIB non-small cell lung cancer. This trial is testing a new way of delivering radiation dose when only the tumor receives dose escalation while the surrounding normal structure is kept at standard level. Photon beam radiation therapy is a type of radiation therapy that uses x-rays or gamma rays that come from a special machine called a linear accelerator (linac). The radiation dose is delivered at the surface of the body and goes into the tumor and through the body. Proton beam radiation therapy is a type of radiation therapy that uses streams of protons (tiny particles with a positive charge) to kill tumor cells. Both methods are designed to give a higher than standard dose of treatment to the tumor and may reduce the amount of radiation damage to healthy tissue near a tumor.
Recruiting1 award Phase 1 & 216 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
More about Zhongxing Liao
Clinical Trial Related12 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Zhongxing Liao has experience with
- Image Guided Radiation Therapy
- Model Based Personalized Chemoradiation
- Intensity-Modulated Radiation Therapy
- Photon Beam Radiation Therapy
- Proton Beam Radiation Therapy
- Carboplatin
Breakdown of trials Zhongxing Liao has run
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zhongxing Liao specialize in?
Zhongxing Liao focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Zhongxing Liao currently recruiting for clinical trials?
Yes, Zhongxing Liao is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Zhongxing Liao has studied deeply?
Yes, Zhongxing Liao has studied treatments such as Image Guided Radiation Therapy, Model Based Personalized Chemoradiation, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Zhongxing Liao?
Apply for one of the trials that Zhongxing Liao is conducting.
What is the office address of Zhongxing Liao?
The office of Zhongxing Liao is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.